As of May 22
| +0.01 / +0.76%|
The 3 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 3.00, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a +127.27% increase from the last price of 1.32.
The current consensus among 3 polled investment analysts is to Buy stock in Navidea Biopharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.